PRL and prostate carcinoma: The results revealed that miR-203 targets were particularly enriched in signaling including pathways in cancer, proteoglycans in cancer, focal adhesion, Wnt, prolactin, FoxO and Ras signaling pathway, as well as some types of cancer including glioma, bladder, pancreatic, and prostate cancer and.